NO152046C - Analogifremgangsmaate ved fremstilling av 1-(p-metoksy-benzoyl)-2-pyrrolidinon - Google Patents

Analogifremgangsmaate ved fremstilling av 1-(p-metoksy-benzoyl)-2-pyrrolidinon

Info

Publication number
NO152046C
NO152046C NO790434A NO790434A NO152046C NO 152046 C NO152046 C NO 152046C NO 790434 A NO790434 A NO 790434A NO 790434 A NO790434 A NO 790434A NO 152046 C NO152046 C NO 152046C
Authority
NO
Norway
Prior art keywords
pyrrolidinon
metoxy
benzoyl
preparation
analogy procedure
Prior art date
Application number
NO790434A
Other languages
English (en)
Norwegian (no)
Other versions
NO152046B (no
NO790434L (no
Inventor
Emilio Kyburz
Werner Aschwanden
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of NO790434L publication Critical patent/NO790434L/no
Priority to NO823800A priority Critical patent/NO155577C/no
Publication of NO152046B publication Critical patent/NO152046B/no
Publication of NO152046C publication Critical patent/NO152046C/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/18Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D207/22Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/24Oxygen or sulfur atoms
    • C07D207/262-Pyrrolidones
    • C07D207/2632-Pyrrolidones with only hydrogen atoms or radicals containing only hydrogen and carbon atoms directly attached to other ring carbon atoms
    • C07D207/272-Pyrrolidones with only hydrogen atoms or radicals containing only hydrogen and carbon atoms directly attached to other ring carbon atoms with substituted hydrocarbon radicals directly attached to the ring nitrogen atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/30Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D207/34Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/36Oxygen or sulfur atoms
    • C07D207/382-Pyrrolones
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/02Silicon compounds
    • C07F7/08Compounds having one or more C—Si linkages
    • C07F7/10Compounds having one or more C—Si linkages containing nitrogen having a Si-N linkage

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • General Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Psychiatry (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrrole Compounds (AREA)
NO790434A 1978-02-10 1979-02-09 Analogifremgangsmaate ved fremstilling av 1-(p-metoksy-benzoyl)-2-pyrrolidinon NO152046C (no)

Priority Applications (1)

Application Number Priority Date Filing Date Title
NO823800A NO155577C (no) 1978-02-10 1982-11-12 Metoksybenzoyl-derivater.

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CH140378 1978-02-10
CH1198178 1978-11-22

Publications (3)

Publication Number Publication Date
NO790434L NO790434L (no) 1979-08-13
NO152046B NO152046B (no) 1985-04-15
NO152046C true NO152046C (no) 1985-07-24

Family

ID=25687541

Family Applications (1)

Application Number Title Priority Date Filing Date
NO790434A NO152046C (no) 1978-02-10 1979-02-09 Analogifremgangsmaate ved fremstilling av 1-(p-metoksy-benzoyl)-2-pyrrolidinon

Country Status (34)

Country Link
US (1) US4369139A (xx)
EP (2) EP0005143B1 (xx)
JP (1) JPS6059907B2 (xx)
AR (1) AR220739A1 (xx)
AT (1) AT374787B (xx)
AU (1) AU525514B2 (xx)
BG (1) BG29281A3 (xx)
BR (1) BR7900684A (xx)
CA (1) CA1100515A (xx)
CS (1) CS226182B2 (xx)
CU (1) CU21107A3 (xx)
DD (1) DD141828A5 (xx)
DE (1) DE2963321D1 (xx)
DK (1) DK155278C (xx)
EG (1) EG13873A (xx)
ES (2) ES477587A1 (xx)
FI (1) FI69063C (xx)
GR (1) GR71464B (xx)
HK (1) HK6185A (xx)
HU (1) HU177644B (xx)
IE (1) IE47831B1 (xx)
IL (1) IL56587A0 (xx)
IN (1) IN150106B (xx)
MC (1) MC1257A1 (xx)
MY (1) MY8500340A (xx)
NO (1) NO152046C (xx)
NZ (1) NZ189571A (xx)
OA (1) OA06180A (xx)
PH (1) PH15491A (xx)
PL (1) PL115958B1 (xx)
PT (1) PT69206A (xx)
RO (1) RO76615A (xx)
SU (1) SU931104A3 (xx)
YU (1) YU41330B (xx)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1131959B (it) * 1979-08-09 1986-06-25 Hoffmann La Roche Derivati pirrolidinici
CH646149A5 (de) * 1981-02-05 1984-11-15 Hoffmann La Roche Pyrrolidin-derivat.
US4398938A (en) * 1982-05-20 1983-08-16 Velsicol Chemical Corporation N-Acylated lactams and their herbicidal compositions and method of use
DE3326724A1 (de) * 1983-07-25 1985-02-07 Boehringer Ingelheim KG, 6507 Ingelheim In 1-stellung substituierte 4-hydroxymethyl-pyrrolidinone, verfahren zu ihrer herstellung, pharmazeutische zusammensetzungen und zwischenprodukte
DE3336024A1 (de) * 1983-10-04 1985-04-18 Boehringer Ingelheim KG, 6507 Ingelheim 4-amino-l-benzyl-pyrrolidinone und ihre saeureadditionssalze, verfahren zu ihrer herstellung und arzneimittel
DE3420193A1 (de) * 1984-05-30 1985-12-05 Boehringer Ingelheim KG, 6507 Ingelheim Neue substituierte pyrrolidinone, verfahren zu ihrer herstellung und arzneimittel
CH661174GA3 (xx) * 1985-07-10 1987-07-15
US4691853A (en) * 1985-12-30 1987-09-08 Technalytics, Inc. Surgical stapler
US5173489A (en) * 1986-04-10 1992-12-22 The Dupont Merck Pharmaceutical Co. α,α-disubstituted aromatics and heteroaromatics as cognition enhancers
US4760083A (en) * 1986-04-10 1988-07-26 E. I. Dupont De Nemours & Company 3,3-disubstituted indolines
US5300642A (en) * 1986-04-10 1994-04-05 The Du Pont Merck Pharmaceutical Company α, α-disubstituted aromatics and heteroaromatics as cognition enhancers
US4876259A (en) * 1987-01-05 1989-10-24 E. I. Du Pont De Nemours And Company 3,3-disubstituted indolines
IT1215587B (it) * 1987-06-26 1990-02-14 Roussel Maestretti Spa Derivati della 1-benzoil2-oxo 5-alcossi pirrolidina, loro procedimento di preparazione e loro impiego come sostanza medicinale.
CA1305148C (en) * 1987-08-19 1992-07-14 Hiromu Matsumura Carbamoylpyrrolidone derivatives and drugs for senile dementia
US5202345A (en) * 1987-08-19 1993-04-13 Shionogi & Co., Ltd. Carbamoylpyrrolidone derivatives and drugs for senile dementia
JP2585086B2 (ja) * 1988-12-28 1997-02-26 大鵬薬品工業株式会社 ジアザビシクロアルカン誘導体
IT1231921B (it) * 1989-06-12 1992-01-15 Sigma Tau Ind Farmaceuti 1-acil-2-pirrolidoni quali attivatori dei processi di apprendimento e della memoria e composizioni farmaceutiche comprendenti tali composti
JP2803882B2 (ja) * 1990-02-20 1998-09-24 日清製粉株式会社 1―フエノキシカルボニル―2―ピロリジノン誘導体
JP3038032B2 (ja) * 1991-03-25 2000-05-08 日清製粉株式会社 血小板凝集抑制薬
ES2210060T3 (es) * 1992-07-24 2004-07-01 The Regents Of The University Of California Farmacos que aumentan las respuestas sinapticas mediadas por receptores ampa.
US5852008A (en) * 1995-01-24 1998-12-22 The Regents Of The University Of California Heteroatom substituted benzoyl derivatives that enhance synaptic response mediated by receptors
US5955505A (en) * 1995-02-21 1999-09-21 Nippon Suisan Kaisha, Ltd. Glutamic acid receptor agonist
IT1318490B1 (it) * 1999-04-27 2003-08-25 Hoffmann La Roche Agente per fare aumentare la cessione di acetilcolina cerebrale.
ATE431142T1 (de) 2000-12-28 2009-05-15 Hamilton Pharmaceuticals Inc Arzneimittel zur behandlung und vermeidung neurogener schmerzen
US8858594B2 (en) * 2008-12-22 2014-10-14 Abbott Laboratories Curved closure device
PL2604592T3 (pl) 2011-12-12 2015-04-30 Zakl Farmaceutyczne Polpharma Sa Sposób oczyszczania aniracetamu przez krystalizacje z roztworów wodnych
CN109651222A (zh) * 2018-12-21 2019-04-19 上海昊航化工有限公司 一种阿尼西坦的催化合成方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3697563A (en) * 1970-06-29 1972-10-10 Inst Chemioterapico Italiano S (3,4,5-trimethoxy-benzamido)-alkanoic acids for prophylaxis and treatment of cardiac disorders
DE2413935A1 (de) * 1974-03-20 1975-10-16 Schering Ag 4-(polyalkoxy-phenyl)-2-pyrrolidone
ES433723A1 (es) * 1975-01-10 1976-11-16 Lafarquim S A Lab Procedimiento de obtencion de un derivado de 2-pirrolidi- nona.

Also Published As

Publication number Publication date
US4369139A (en) 1983-01-18
ATA99579A (de) 1983-10-15
EP0044088A3 (en) 1982-02-03
OA06180A (fr) 1981-06-30
FI790226A (fi) 1979-08-11
MC1257A1 (fr) 1980-01-14
FI69063C (fi) 1985-12-10
DK155278C (da) 1989-07-24
IE47831B1 (en) 1984-06-27
AU4391679A (en) 1979-08-16
AU525514B2 (en) 1982-11-11
EP0044088A2 (de) 1982-01-20
ES483756A1 (es) 1980-04-16
ES477587A1 (es) 1980-01-16
RO76615A (ro) 1981-04-30
PL115958B1 (en) 1981-05-30
DE2963321D1 (en) 1982-09-02
NZ189571A (en) 1984-07-06
DK56379A (da) 1979-08-11
IL56587A0 (en) 1979-05-31
NO152046B (no) 1985-04-15
EG13873A (en) 1982-12-31
AR220739A1 (es) 1980-11-28
EP0005143B1 (de) 1982-07-14
CU21107A3 (es) 1988-02-01
AT374787B (de) 1984-05-25
YU28379A (en) 1983-02-28
CA1100515A (en) 1981-05-05
GR71464B (xx) 1983-05-30
JPS6059907B2 (ja) 1985-12-27
PH15491A (en) 1983-01-31
IE790246L (en) 1979-08-20
NO790434L (no) 1979-08-13
DK155278B (da) 1989-03-20
HU177644B (en) 1981-11-28
MY8500340A (en) 1985-12-31
JPS54117468A (en) 1979-09-12
HK6185A (en) 1985-02-01
SU931104A3 (ru) 1982-05-23
DD141828A5 (de) 1980-05-21
FI69063B (fi) 1985-08-30
PL213340A1 (xx) 1980-03-24
BR7900684A (pt) 1979-09-04
EP0044088B1 (de) 1984-02-22
PT69206A (en) 1979-03-01
IN150106B (xx) 1982-07-24
BG29281A3 (en) 1980-10-15
YU41330B (en) 1987-02-28
CS226182B2 (en) 1984-03-19
EP0005143A1 (de) 1979-11-14

Similar Documents

Publication Publication Date Title
NO152046C (no) Analogifremgangsmaate ved fremstilling av 1-(p-metoksy-benzoyl)-2-pyrrolidinon
NO790257L (no) Fremgangsmaate ved fremstilling av 9-desoksy-9a-metylen-isostere av pgi2
NO792760L (no) Fremgangsmaate ved fremstilling av nye nafthydrinderivater
NO801155L (no) Fremgangsmaate ved fremstilling av acyl-carnitinamider
NO792240L (no) Fremgangsmaate ved fremstilling av platina-diaminkomplekser
NO792823L (no) Fremgangsmaate ved fremstilling av nye arginiamidderivater
NO148281C (no) Fremgangsmaate ved fremstilling av allergenholdige forbindelser
NO810358L (no) Fremgangsmaate ved fremstilling av antihypercholesterolemiske
NO149324C (no) Fremgangsmaate ved behandling av en underjordisk formasjon
NO802913L (no) Fremgangsmaate ved fremstilling av cephalosporinforbindelse
NO800030L (no) Fremgangsmaate ved fremstilling av 2-penem-forbindelser
NO792267L (no) Fremgangsmaate ved fremstilling av substituerte benzapiner
NO791042L (no) Fremgangsmaate ved foredling av cellulosemasser
NO792474L (no) Fremgangsmaate ved fremstilling av indanyl-derivater
NO790285L (no) Fremgangsmaate ved fremstilling av nye 2-pyrrolidon-forbindelser
FI791562A (fi) Foerfarande foer framstaellning av 4-amino-2-piperidinokinazolinderivat
SE7902238L (sv) Forfarande for bestemning av alfa-amylas
NO791440L (no) Fremgangsmaate ved fremstilling av 6-halogen-pregnaner
NO791217L (no) Fremgangsmaate ved fremstilling av forbindelser med fosforcarbon-nitrogen-binding
NO152413C (no) Analogifremgangsmaate ved fremstilling av immunstimulerende n-substituerte aziridin-2-cyanderivater
FI793307A (fi) Foerfarande foer framstaellning av 6-piperidino-2,4-diaminopyrimidin-3-oxid
NO801982L (no) Fremgangsmaate ved fremstilling av svovelholdige isokinolinderivater
NO793897L (no) Fremgangsmaate ved dealkylering av alkylfenoler.
NO812467L (no) Fremgangsmaate ved fremstilling av as-triazinderivater
NO791220L (no) Fremgangsmaate ved fremstilling av 4-aza-17-substituert-5alfa-androstan-3-oner